John Najim
Technik-/Wissenschafts-/F&E-Leiter bei DYNE THERAPEUTICS, INC.
Profil
John Najim is currently the Chief Technical Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as an Associate Director-Manufacturing at Dyax Corp.
and as the VP-Manufacturing & Process Development at Proteon Therapeutics, Inc. from 2009 to 2019.
Mr. Najim holds an MBA from Bentley University and an undergraduate degree from Merrimack College.
Aktive Positionen von John Najim
| Unternehmen | Position | Beginn |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Ehemalige bekannte Positionen von John Najim
| Unternehmen | Position | Ende |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2019 |
| DYAX CORP. | Corporate Officer/Principal | - |
Ausbildung von John Najim
| Merrimack College | Undergraduate Degree |
| Bentley University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
